BLOG

Tuesday, August 13, 2019

Dr Reddy's Labs slumps 8% as US FDA issues CRL for its version of NuvaRing

A CRL is issued when the FDA decides not to approve new or generic drug application for marketing in its present form

from Home Page https://ift.tt/2KN96xk
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...